Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Interstitial lung disease
ADR ID BADD_A02378
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.01      Immune and associated conditions NEC
10.02.01.033      Interstitial lung disease
22      Respiratory, thoracic and mediastinal disorders
22.01      Lower respiratory tract disorders (excl obstruction and infection)
22.01.02      Parenchymal lung disorders NEC
22.01.02.003      Interstitial lung disease
Description A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features. [MeSH]
MedDRA Code 10022611
MeSH ID D017563
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Interstitial lung disease | Interstitial lung fibrosis | Interstitial pneumonia | Interstitial pneumonitis | Interstitial pulmonary fibrosis | Lung fibrosis interstitial | Pneumonia interstitial | Pneumonia interstitial diffuse | Acute diffuse infiltrative lung disease | Chronic interstitial pneumonia | Interstitial pneumonia aggravated | Follicular bronchiolitis | Progressive fibrosing interstitial lung disease | Interstitial lung disease with a progressive phenotype | Idiopathic interstitial lung disease | PF-ILD | Granulomatous lymphocytic interstitial lung disease | Lung Diseases, Interstitial | Interstitial Lung Disease | Lung Disease, Interstitial | Interstitial Lung Diseases | Diffuse Parenchymal Lung Diseases | Pneumonia, Interstitial | Interstitial Pneumonia | Interstitial Pneumonias | Pneumonias, Interstitial | Pneumonitis, Interstitial | Interstitial Pneumonitides | Interstitial Pneumonitis | Pneumonitides, Interstitial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01254Lenvatinib0.003694%
BADD_D01257Letrozole0.003029%
BADD_D01261Leuprolide monoacetate--
BADD_D01275Levofloxacin--
BADD_D01295Linezolid0.018112%
BADD_D01336Macitentan0.002130%
BADD_D01350Maprotiline--
BADD_D01351Maprotiline hydrochloride--
BADD_D01376Melphalan--
BADD_D01377Melphalan hydrochloride--
BADD_D01393Meropenem0.000073%
BADD_D01397Mesalamine0.001464%
BADD_D01418Methotrexate0.006083%
BADD_D01433Methylprednisolone0.000224%
BADD_D01445Metoprolol0.000127%
BADD_D01470Minocycline0.000413%
BADD_D01480Mitoxantrone--
BADD_D01481Mitoxantrone hydrochloride--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid0.001427%
BADD_D01511Nabumetone--
BADD_D01513Nafarelin--
BADD_D01533Naproxen0.000029%
BADD_D01566Nifedipine0.000149%
BADD_D01567Nilotinib--
BADD_D01568Nilutamide--
BADD_D01574Nitric oxide-
BADD_D01576Nitrofurantoin0.000149%
BADD_D01601Olaparib0.007387%
BADD_D01607Olsalazine--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 9 Pages